HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.

AbstractOBJECTIVES:
Cancer patients generally exhibit circulating tumor-reactive immunoglobulins; however, these antibodies fail to eradicate tumors or prevent their progression. This study identifies and characterizes an aberrant tumor-reactive IgG population present in women with ovarian cancer.
METHODS:
In this pilot study, IgG was isolated from the sera of women with advanced-stage ovarian cancer (stages III and IV, n = 62) and age-matched female volunteers (n = 50) by affinity chromatography. These IgGs were characterized on the basis on their aberrant binding to concanavalin A affinity columns. Subsequently, the concanavalin A-binding moiety was localized following IgG fragmentation, analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and characterized by oligosaccharide profiling.
RESULTS:
The level of concanavalin A-binding IgG in our control population was 8.9 +/- 2.9%, whereas in ovarian cancer patients, the level of concanavalin A-binding IgG was 38.8 +/- 7.4%. In the patients with ovarian cancer, 87.5 +/- 5.7% of the tumor-reactive IgG was demonstrated to be concanavalin A-binding. Based on oligosaccharide profiling of the fragmented concanavalin A-binding IgG, the aberrant lectin binding appeared to be the consequence of altered glycosylation of one of the two Fc chains.
CONCLUSIONS:
While our previous studies have identified the presence of circulating IgG reactive with specific tumor-associated antigens and its association with poor prognosis, this report demonstrated the presence of an aberrantly glycosylated IgG population in cancer patients. This altered IgG appeared to be the primary class of tumor-reactive antibodies in these women.
AuthorsC Gerçel-Taylor, L B Bazzett, D D Taylor
JournalGynecologic oncology (Gynecol Oncol) Vol. 81 Issue 1 Pg. 71-6 (Apr 2001) ISSN: 0090-8258 [Print] United States
PMID11277653 (Publication Type: Journal Article)
CopyrightCopyright 2001 Academic Press.
Chemical References
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Immunoglobulin G
  • Oligosaccharides
  • Receptors, Concanavalin A
  • Concanavalin A
Topics
  • Antibodies, Neoplasm (blood, immunology)
  • Antigens, Neoplasm (immunology)
  • Chromatography, Affinity
  • Concanavalin A (immunology, metabolism)
  • Female
  • Humans
  • Immunoglobulin G (blood, immunology, isolation & purification)
  • Middle Aged
  • Neoplastic Cells, Circulating (immunology)
  • Oligosaccharides (immunology, metabolism)
  • Ovarian Neoplasms (blood, immunology, pathology)
  • Pilot Projects
  • Receptors, Concanavalin A (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: